NCT04746092 2021-08-16
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
Tel-Aviv Sourasky Medical Center
Unknown
Clinical Trials
11 trialsNCT04364724 2020-04-28
CTFEA Myeloma Study
Tel-Aviv Sourasky Medical Center
Unknown
NCT03908138 2019-11-29
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
Shandong Provincial Hospital
Phase 4 Unknown
NCT03601624 2018-11-14
MM-POM-2018
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Phase 2 Unknown
NCT03664661 2018-09-10
BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma
Henan Cancer Hospital
Phase 1 Unknown
NCT03322735 2017-12-29
Study of BCMA CAR-T in Multiple Myeloma
Henan Cancer Hospital
Phase 1/2 Unknown
NCT02488382 2017-10-17
Lonquek for Autologous Stem Cell Mobilization
Sheba Medical Center
Phase 1/2 Unknown
NCT02507479 2016-04-20
Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Sheba Medical Center
Phase 2 Unknown
NCT01171443 2010-07-28
BIPN
Wolfson Medical Center
Unknown
NCT00872352 2009-03-31
Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients
Wolfson Medical Center
Phase 3 Unknown
NCT00164086 2006-10-11
Atorvastatin in Myeloma
Bayside Health
Phase 1 Unknown